Gefitinib - PDFSEARCH.IO - Document Search Engine

Gefitinib
Results: 146

#	Item
31	Pharmacogenomics of EGFR-targeted therapies in nonŁsmall cell lung cancer: EGFR and beyond Add to Reading List Source URL: www.cjcjournal.com Language: English Tyrosine kinase receptors Quinazolines Organofluorides Oncogenes Amines Epidermal growth factor receptor Cetuximab Gefitinib Erlotinib Chemistry Medicine Biology
32	Future challenges to HTA Policy challenges Prince of Wales clinical school and Lowy cancer research centre Co-dependent technologies Add to Reading List Source URL: pbs.gov.au Language: English - Date: 2014-10-01 21:56:49 Organochlorides Organofluorides Amines Quinazolines Lung cancer KRAS Personalized medicine Gefitinib BRAF Medicine Chemistry Organic chemistry
33	PUBLIC SUMMARY DOCUMENT Product: Gefitinib, tablet, 250 mg, Iressa® Sponsor: AstraZeneca Pty Limited Date of PBAC Consideration: NovemberPurpose of Application Add to Reading List Source URL: www.pbs.gov.au Language: English - Date: 2014-10-01 21:56:22 Organofluorides Amines Lung cancer Organochlorides Gefitinib Non-small-cell lung carcinoma Epidermal growth factor receptor Protein kinase inhibitor KRAS Chemistry Organic chemistry Quinazolines
34	NDAS-008 Page 3 FOR ONCOLOGY USE ONLY DESCRIPTION Add to Reading List Source URL: www.accessdata.fda.gov Language: English - Date: 2009-03-31 15:17:24 Amines Quinazolines Lung cancer Organofluorides Cancer treatments Gefitinib Non-small-cell lung carcinoma Chemotherapy Methadone Medicine Chemistry Organic chemistry
35	VI. CANCER DE PULMON 1. Genotyping non-small cell lung cancer (NSCLC) in Latin America Arrieta O, Cardona AF, Federico Bramuglia G, Gallo A, Campos-Parra AD, Serrano S, Castro M, Avilés A, Amorin E, Kirchuk R, Cuello M Add to Reading List Source URL: www.inen.sld.pe Language: English - Date: 2014-03-13 18:40:55 KRAS Chemistry Non-small-cell lung carcinoma Protein kinase inhibitor Cetuximab Gefitinib Lung cancer Medicine Oncology
36	QSAR based model for discriminating EGFR inhibitors and non-inhibitors using Random forest Add to Reading List Source URL: www.biologydirect.com Language: English Quinazolines Tyrosine kinase receptors Alkynes Organofluorides Epidermal growth factor receptor Erlotinib Gefitinib Fingerprint Protein kinase inhibitor Chemistry Organic chemistry Amines
37	AstraZeneca submission to the Post-Market Review of Authority Required PBS listings AstraZeneca welcomes the opportunity to contribute to the Post-Market Review of Authority Required Pharmaceutical Benefits Schedule (PBS Add to Reading List Source URL: pbs.gov.au Language: English - Date: 2015-03-02 18:33:44 Quinazolines Organofluorides Amines Organochlorides Pharmaceutical Benefits Scheme Protein kinase inhibitor Quality use of medicines Gefitinib Erlotinib Chemistry Organic chemistry AstraZeneca
38	The HDAC inhibitor, MPT0E028, enhances erlotinib-induced cell death in EGFR-TKI-resistant NSCLC cells Add to Reading List Source URL: www.nature.com Language: English - Date: 2013-09-19 09:55:19 Quinazolines Amines Tyrosine kinase receptors Lung cancer Organofluorides Erlotinib Gefitinib Epidermal growth factor receptor Targeted therapy Chemistry Medicine Organic chemistry
39	Microsoft Word - Figure 1 Orzaez CDDis Add to Reading List Source URL: www.nature.com Language: English - Date: 2012-10-25 05:59:49 Cell signaling Apoptosis Caspase 3 Erlotinib Targeted therapy Gefitinib Caspase Fas receptor Epidermal growth factor receptor Biology Cell biology Programmed cell death
40	OPEN Citation: Cell Death and Disease[removed], e1260; doi:[removed]cddis[removed] & 2014 Macmillan Publishers Limited All rights reserved[removed]www.nature.com/cddis Add to Reading List Source URL: www.nature.com Language: English - Date: 2014-05-29 08:44:58 Organic chemistry Non-small-cell lung carcinoma ERCC1 Gefitinib MicroRNA Epidermal growth factor receptor Erlotinib KRAS Cetuximab Chemistry Lung cancer Medicine